论文部分内容阅读
近年来,随着细胞免疫学研究的进展和生物学技术的进步,应用免疫学方法治愈人类癌肿的研究日新月异,IL-2/LAK细胞疗法就是近几年发展起来的肿瘤免疫疗法,国外已将该疗法用于监床试治并取得了令人瞩目的疗效。国内少数条件较好的研究机构如哈医大肿瘤研究所、上海第二医科大学、东北师大生物系等单位,亦开展了这方面的研究工作,监床实施IL-2/LAK细胞疗法治疗肝癌、肺癌、膀胱癌、卵巢癌、肾癌、黑色素
In recent years, with the progress of cellular immunology and advances in biological technology, the research on immunotherapy to cure human cancer is rapidly changing. IL-2 / LAK cell therapy is a tumor immunotherapy developed in recent years. The treatment for trial bed and has achieved remarkable results. A few well-established research institutions such as Harbin Medical University Cancer Institute, Shanghai Second Medical University, Northeast Normal University Department of Biology and other units, also carried out research in this area, the clinical implementation of IL-2 / LAK cell therapy for the treatment of liver cancer , Lung cancer, bladder cancer, ovarian cancer, kidney cancer, melanin